InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the detailed record of transactions filed by Contamine Jérôme. Officer active across 1 company, notably LAKEFRONT BIOTHERAPEUTICS. In total, 1 disclosures have been published. History available since 22 January 2026. The latest transaction was filed on 22 January 2026 (Purchase). Regulator: FSMA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条